Catalent's (CTLT.N) plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk's (NOVOb.CO) weight-loss drug Wegovy as part of the two companies' expanded supply agreement, two sources familiar with the matter told Reuters.
A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/File Photoweight-loss drug Wegovy as part of the two companies' expanded supply agreement, two sources familiar with the matter told Reuters.Novo is spending billions of dollars to make more of its obesity drug amid sky-rocketing demand, particularly in the United States.
But Novo has struggled to keep up with demand even as it has added production capacity, in part because of problems Catalent has had at the Brussels plant.When asked on Friday about Catalent's issues, Jorgensen said he was confident the company would resolve its problems.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Ozempic, Wegovy may be linked to stomach paralysis and other digestive issues in large-scale studyPopular weight loss drugs like Wegovy and Ozempic could increase the risk of stomach paralysis as well as several other serious gastrointestinal conditions, according to a study published in JAMA.
続きを読む »
What to Know About Hitting a Weight Loss Plateau While on Ozempic or WegovyIf you take Ozempic or Wegovy, will you keep losing weight or hit a plateau? Even though a plateau can be inevitable, staying on the drugs can help you maintain your weight loss.
続きを読む »
No more monkey business: Police capture 'Momo' safelyPolice in Indiana capture monkey on the loose
続きを読む »
From the Rev. Henry Beecher, of Indianapolis, Indiana.We have a school fund of more than two millions, which is in such neglect as threatens its entire loss.
続きを読む »